Compare · 2 funds side by side · dividends reinvested

PBE and GNOM

PBEInvesco×GNOMGlobal X×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$13,865PBE · best of the two

02 / 04

PBE and GNOM, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Invesco Biotechnology & Genome ETFSectors · Technology0.59%1.30%+25.9%+39.0%+25.8%+6.8%−11.7%19.8%$435M1.4

Global X - Genomics & Biotechnology ETFSectors · Technology0.50%0.95%+49.8%+51.7%+25.3%−4.4%−18.2%33.6%$109M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: PBE 2005 · GNOM 2019

Head to Head

Swap sides Versus in desk

Head to Head

Invesco Biotechnology & Genome ETF · $435M$13,865

PBE

GNOM

Global X - Genomics & Biotechnology ETF · $109M$7,969

$10,000 five years ago, dividends reinvested · they hold 31.2% in common

PBEMeasureGNOM

+25.9%Year to dateJan 1 → Nov 3+49.8%

+39.0%1 yearTotal return+51.7%

+25.8%3 years · per year$10,000 became $19,930 · $19,656+25.3%

+6.8%5 years · per year$10,000 became $13,865 · $7,969−4.4%

0.59%Expense ratio$59 · $50 a year on $10k · lower is better0.50%

1.30%Trailing 12-mo yield$130 · $95 a year on $10k0.95%

−11.7%Worst dropSmaller is better−18.2%

19.8%VolatilityLower is calmer33.6%

PBEGNOM Winner of the row, in its colourEach row: the bigger of the two fills its side

5–3PBE wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

PBE vs GNOM: Top 5 Holdings

Today

PBE

27.4%in top 5

GNOM

in top 534.2%

PBEStockGNOM

not top 5MRNA11.0%

not top 5TWST6.5%

not top 5TXG5.7%

5.6%REGNnot top 5

5.6%GILDnot top 5

5.5%BIIBnot top 5

not top 5GH5.5%

5.5%NTRA5.5%

5.2%RPRXnot top 5

Held in common31.2%

End-of-day Nov 3, 2026 · share of each fund

PBE vs GNOM Returns, Every Period

InvescoPBE

+6.8%

5 years, per year

GNOMGlobal X

−4.4%

5 years, per year

PBEGNOMFaded: behind in that period

2–2Level

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

PBE vs GNOM

YTD

InvescoPBE

+25.9%

GNOMGlobal X

+49.8%

+25.9%Year to date+49.8%

−11.7%Worst drop · 1Y−18.2%

19.8%Volatility · 1Y33.6%

1.3%Yield1.0%

$435MAssets$109M

3–1PBE wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: PBE, GNOM

Today

0.50%lowest, GNOM

FundExpense ratioFee$10k

GNOM0.50%$50

PBE0.59%$59

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: PBE, GNOM

1.30%highest, PBE

FundTrailing yieldYield$10k

PBE1.30%$130

GNOM0.95%$95

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$71most kept, PBE

PBE$130 − $59 = $71

GNOM$95 − $50 = $45

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: PBE, GNOM

Today

31.2%most shared, PBE and GNOM

PBEGNOM

PBE—31.2%

GNOM31.2%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+51.7%GNOM, at 33.6% volatility

PBEWorst drop−11.7%19.8% vol

GNOMWorst drop−18.2%33.6% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

PBEGNOM

+25.9%Year to date+49.8%

1.3%Yield1.0%

+39.0%Past year+51.7%

0.59%Fee0.50%

3–1GNOM wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026